All News #Library
Biotech
Formation Bio Licenses MIR-124 Activator For Autoimmune Diseases
29 Jan 2026 //
PR NEWSWIRE
Lynk Pharma, Formation Bio Ink Exclusive Deal For LNK01006
10 Dec 2025 //
PR NEWSWIRE
Formation Boosts Leadership Team for AI-Driven Drug Development
18 Sep 2025 //
PR NEWSWIRE
Formation Bio Licenses Anti-CD226 Program from IMIDomics
29 Jul 2025 //
PR NEWSWIRE
Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor
24 Jun 2025 //
PR NEWSWIRE
Formation Bio Names First Entrepreneurs in Residence Class
09 Jun 2025 //
PR NEWSWIRE

Market Place
Sourcing Support